Elizabeth Dragon, the former senior vice president of research and development at San Diego-based genetic analysis company Sequenom, was charged June 2 with lying to investors about the accuracy of the company’s prenatal test for Down syndrome, according to the Securities and Exchange Commission...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129